Healthcare News

Young women undergoing chemotherapy for breast cancer may be more likely to remain fertile if they also receive hormonal treatment, according to new research presented to the 2015 European Cancer Congress 1 on Monday and published simultaneously in Annals of Oncology.2

A new study will help physicians evaluate simple fertility treatments for couples who have unexplained infertility, defined as being unable to get pregnant after trying for a year without success for no apparent reason.

Men diagnosed with infertility have a higher risk of developing other general health ailments, including diabetes, ischemic heart disease, alcohol abuse and drug abuse, compared with fertile men, according to a study.

A new technique developed by a team of researchers affiliated with a number of facilities in China allows medical practitioners involved in IVF treatment to more easily weed out embryos with genetic defects prior to fertilization and implantation of a zygote into a host uterus.

Humans and worms are connected by a common ancestor that lived more than 700 million years ago and shared a gene that is required for sperm to function properly at fertilization, research confirms. This discovery could lead to more effective infertility treatments and better contraceptives.

A potential new approach to fertility preservation for young cancer patients has been discovered, which addresses concerns about beginning cancer treatment immediately and the possibility of reintroducing cancer cells during the fertility preservation process.

Compared with receiving chemotherapy alone, women with breast cancer who also received the hormonal drug triptorelin to achieve ovarian suppression had a higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate or disease-free survival, according to a study.

The potent humanin analogue protects male germ cells, which are essential to fertility, and white blood cells, which are the soldiers in the body's defense system, during chemotherapy, new research shows.